1 Pope J . An update in pulmonary hypertension in systemic lupus erythematosus – do we need to know about it. Lupus2008; 17: 274–277.
2.
2 Badesch DB Abman SH Ahearn GS . Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest2004; 126: 35S–62S.
3.
3 Sodhi M Krasuski R Dweik RA Minai OA . Vasoreactivity in pulmonary hypertension. Am J Respir Crit Care Med2008; 177: A920.
4.
4 Chung S-M Lee C-K Lee EY Yoo B Lee S-D Moon H-B . Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol2006; 25: 866–872.
5.
5 Barst RJ McGoon M McLaughlin VV . Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol2003; 41: 2119–2125.
6.
6 Heresi GA Minai OA . Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy. Respir Med2007; 101: 2099–2107.